Publication Date
12-1-2022
Journal
Pediatric Transplantation
DOI
10.1111/petr.14351
PMID
35799318
PMCID
PMC9350339
Published Open-Access
no
Keywords
Humans, Child, Infant, Newborn, Infant, Child, Preschool, Adolescent, COVID-19, SARS-CoV-2, Lung Transplantation
Abstract
BACKGROUND: SARS-CoV-2 infection in the age group of 0-17 years contributes to approximately 22% of all laboratory-confirmed SARS-CoV-2 infections. Fortunately, this age group has a lower death rate (0.5 per 100 000) that accounts for only 4% of the total deaths due to COVID-19. Despite the low mortality rate in the pediatric population, children of minority groups represented 78% of the deaths highlighting the existing disparities in access to health care.
METHODS: With the emergence of the more contagious COVID-19 variants and the relatively slow pace of vaccination among the pediatric population, it is possible to see more cases of significant lung injury and potential for transplantation for the younger age group.
RESULTS: To our knowledge, our patient is the youngest to have undergone lung transplantation for SARS-CoV-2.
CONCLUSION: The case presented unique challenges, particularly in relation to timing for listing and psychosocial support for parents who were his decision makers.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, COVID-19 Commons, Epidemiology Commons, Medical Sciences Commons, Medical Specialties Commons, Mental and Social Health Commons, Psychiatry and Psychology Commons
Comments
Associated Data